title: Treatment of posttranplant hypertension: ACE is trumped?
authors.affiliation: The Richard Bright Renal Unit, Southmead Hospital, Westbury-on-Trym, Bristol, UK.
authors.forename: C R
authors.initials: CR
authors.lastname: Dudley
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D016572:Cyclosporine / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000009:adverse effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D016572:Cyclosporine